Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Podobne knjige/članki

• P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
  od: Allen, MA, et al.
  Izdano: (2009)
• Self-reported Benefits of Study Participation in HVTN 503, “Phambili”
  od: Allen, Mary A., et al.
  Izdano: (2014)
• P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
  od: Gray, GE, et al.
  Izdano: (2009)
• Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa
  od: Gray, GE, et al.
  Izdano: (2011)
• The phase 2b HVTN 503/Phambili study test-of-concept HIV vaccine study, investigating a recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up
  od: Gray, Glenda E, et al.
  Izdano: (2014)